Alice Blue Home
URL copied to clipboard

Trending News

Thyrocare Technologies: Stock jumps after announcing strong results, 2:1 bonus shares and dividend

Thyrocare Technologies Limited reported Q2 FY26 net profit of ₹47.81 crore, with 25% QoQ and 81% YoY growth, revenue at ₹216.53 crore, and approved interim dividend, bonus issue.

Introduction

Leading diagnostic services provider reported Q2 FY26 net profit of ₹47.81 crore, revenue of ₹216.53 crore, and total income of ₹219.58 crore, declaring ₹7/share interim dividend and 2:1 bonus issue.

Alice Blue Image

Also Read: Lloyds Engineering: Stock jumps after signing new MoU with Poland based firm for drones for Indian defence

Share price movement of Thyrocare Technologies

On October 15, 2025, Thyrocare Technologies Ltd opened at ₹1,470.00, up 16.25% from its previous close of ₹1,264.60. The stock reached a high of ₹1,470.00 and a low of ₹1,264.15. By 12:03 PM, it traded at ₹1,274.95, a 0.82% increase, with a market cap of ₹6,756.53 crore.

Thyrocare Reports Strong Q2 FY26 Results

Thyrocare Technologies Limited reported a strong rise in net profit for Q2 FY26, reaching ₹47.81 crore, up 25% quarter-on-quarter from ₹38.29 crore and 81% year-on-year from ₹26.42 crore, reflecting robust business performance.

Revenue from operations increased to ₹216.53 crore in Q2 FY26, marking a 12% rise compared to ₹193.03 crore in Q1 FY26 and a 22% growth over ₹177.36 crore in Q2 FY25, highlighting sustained demand for diagnostic services.

Total income for Q2 FY26 stood at ₹219.58 crore, showing a 11% quarter-on-quarter increase from ₹197.68 crore and 22% year-on-year growth from ₹179.97 crore, driven by higher operational efficiency and expansion across geographies.

The Board declared an interim dividend of ₹7 per share and recommended a 2:1 bonus issue, celebrating its 25th anniversary and rewarding shareholders, subject to regulatory approvals and the record date fixed on October 24, 2025.

Stock performance of Thyrocare Technologies for Period of 1 week, 6 months, and 1 year

Thyrocare Technologies Ltd delivered a 2.73% return over the past week, gained 78.5% in the past six months, and rose 52.6% over the past year.

Alice Blue Image

Also Read: Highway Infrastructure: Stock jumps 3% after receiving LoA for operation of 8 lane expressway at Laban Village

Shareholding pattern of Thyrocare Technologies

ParticularsSep 2025Jun 2025Mar 2025
Promoter71.10%71.10%71.10%
FII4.90%3.20%2.40%
DII13.50%14.50%15.00%
Public10.60%11.20%11.60%

About Thyrocare Technologies

Thyrocare Technologies Ltd (NSE: THYROCARE) operates in the healthcare sector, offering quality diagnostic services at affordable rates to patients, laboratories, and hospitals across India, focusing on reliable, accessible, and efficient healthcare solutions.

Stay Ahead with the Latest Stock Market Updates – Click Here

Disclaimer: The above article is written for educational purposes, and the companies’ data mentioned in the article may change with respect to time. The securities quoted are exemplary and are not recommendatory.

FAQs

Q: Why is Thyrocare Technologies Ltd share price going up today?

A: Thyrocare Technologies Ltd share price rose due to Q2 FY26 net profit of ₹47.81 crore, revenue of ₹216.53 crore, and approved interim dividend, bonus issue.

Q: What does Thyrocare Technologies Ltd specialize in?

A: Thyrocare Technologies Ltd specializes in providing quality diagnostic services to patients, laboratories, and hospitals across India at affordable rates.

Q: What is the market capitalization of Thyrocare Technologies Ltd?

A: The market capitalization of Thyrocare Technologies Ltd is ₹6,756.53 crore as of October 15, 2025.

Submit the form, and get to know how you scored!!!

Gainers & Losers

Read More News

*T&C apply